Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial 2019-10-09 17:56
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer 2019-10-08 08:00
Cross-industrial technologies make a splash in Asia Agri-Tech Expo in Taipei 2019-10-05 10:06
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations 2019-10-01 07:00
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis 2019-09-30 15:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications 2019-09-25 18:44
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications 2019-09-25 18:35
AGC Biologics Appoints New Site Head/General Manager of Chiba, Japan Operations 2019-09-25 01:42
Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market 2019-09-24 23:28
China Biologic Forms Special Committee to Review "Going Private" Proposal 2019-09-24 20:00
binx health Announces First Patients Benefiting From Single-Visit Test and Treatment for Chlamydia and Gonorrhea 2019-09-23 20:30
CARsgen Announces Investigational CAR-T Therapy CT053 Granted PRIME Eligibility by the European Medicines Agency 2019-09-23 18:00
2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors 2019-09-22 14:22
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab 2019-09-22 13:39
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019 2019-09-20 19:00
Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation 2019-09-19 23:12
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal 2019-09-19 04:01
Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection 2019-09-17 21:00
1 308 309 310 311 312 451